UroMems says that the entire treatment cohort in tae first-of-its-kind study in female patients successfully reached its primary endpoints.

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its ...

Valencia Technologies, a neuromodulation company focused on minimally invasive treatment of urinary incontinence, announced a ...